Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Advances in Clinical Chemistry
|
March 21, 2024
Advances in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Frontiers in Cardiovascular Medicine
|
May 2, 2022
The Evolving Story of Multifactorial Chylomicronemia Syndrome
Martine Paquette, Sophie Bernard
Current Opinion in Lipidology
|
May 1, 2018
Predicting cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Atherosclerosis
|
September 21, 2021
Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Clinical Biochemistry
|
February 18, 2019
SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
April 11, 2017
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Current Opinion in Lipidology
|
January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian population
Martine Paquette, Jacques Genest, Alexis Baass
The Canadian Journal of Cardiology
|
September 25, 2017
Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
May 23, 2018
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
January 2, 2018
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Advances in Clinical Chemistry
|
March 21, 2024
Advances in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Frontiers in Cardiovascular Medicine
|
May 2, 2022
The Evolving Story of Multifactorial Chylomicronemia Syndrome
Martine Paquette, Sophie Bernard
Current Opinion in Lipidology
|
May 1, 2018
Predicting cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Alexis Baass
Atherosclerosis
|
September 21, 2021
Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Clinical Biochemistry
|
February 18, 2019
SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia
Martine Paquette, Sophie Bernard, Alexis Baass
Journal of Clinical Lipidology
|
April 11, 2017
The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Current Opinion in Lipidology
|
January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian population
Martine Paquette, Jacques Genest, Alexis Baass
The Canadian Journal of Cardiology
|
September 25, 2017
Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
May 23, 2018
PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Journal of Clinical Lipidology
|
January 2, 2018
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
Martine Paquette, Robert Dufour, Alexis Baass
Page
of 8